{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:34:51Z","timestamp":1790181291039,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1378\/chest.13-2538","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T11:11:31Z","timestamp":1390475491000},"page":"276-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":318,"title":["Macrolide\/Azalide Therapy for Nodular\/Bronchiectatic Mycobacterium avium Complex Lung Disease"],"prefix":"10.1016","volume":"146","author":[{"suffix":"Jr","given":"Richard J.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Brown-Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie V.","family":"Philley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Killingley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna S.","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6 pt 1","key":"10.1378\/chest.13-2538_bib1","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1164\/ajrccm.153.6.8665029","article-title":"Mycobacterium avium disease: progress at last","volume":"153","author":"Bates","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1378\/chest.13-2538_bib2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.7326\/0003-4819-121-12-199412150-00001","article-title":"Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team","volume":"121","author":"Chaisson","year":"1994","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1378\/chest.13-2538_bib3","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1378\/chest.107.4.1035","article-title":"Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS","volume":"107","author":"Dautzenberg","year":"1995","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.13-2538_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/ajrccm.149.5.8173775","article-title":"Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease","volume":"149","author":"Wallace","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"6 pt 1","key":"10.1378\/chest.13-2538_bib5","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1164\/ajrccm.153.6.8665032","article-title":"Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients","volume":"153","author":"Wallace","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.13-2538_bib6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/clinids\/23.5.983","article-title":"Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus","volume":"23","author":"Griffith","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1378\/chest.13-2538_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1086\/515597","article-title":"Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients","volume":"178","author":"Griffith","year":"1998","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1378\/chest.13-2538_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1086\/313644","article-title":"Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex","volume":"30","author":"Griffith","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1378\/chest.13-2538_bib9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1164\/ajrccm.160.3.9811086","article-title":"Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease","volume":"160","author":"Tanaka","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.13-2538_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/thorax.56.3.167","article-title":"First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol","volume":"56","author":"Research Committee of the British Thoracic Society","year":"2001","journal-title":"Thorax"},{"issue":"4","key":"10.1378\/chest.13-2538_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10156-006-0457-8","article-title":"Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates","volume":"12","author":"Kobashi","year":"2006","journal-title":"J Infect Chemother"},{"key":"10.1378\/chest.13-2538_bib12","doi-asserted-by":"crossref","unstructured":"Kobashi Y, Abe M, Mouri K, Obase Y, Miyashita N, Oka M. Clinical usefulness of combination chemotherapy for pulmonary Mycobacterium avium complex disease [published online ahead of print November 19, 2010]. J Infect;doi:10.1016\/j.jinf.2010.11.011 [withdrawn].","DOI":"10.1016\/j.jinf.2010.11.011"},{"issue":"4","key":"10.1378\/chest.13-2538_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10156-011-0351-x","article-title":"Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period","volume":"18","author":"Kobashi","year":"2012","journal-title":"J Infect Chemother"},{"issue":"13","key":"10.1378\/chest.13-2538_bib14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1056\/NEJM198909283211304","article-title":"Infection with Mycobacterium avium complex in patients without predisposing conditions","volume":"321","author":"Prince","year":"1989","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1378\/chest.13-2538_bib15","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1164\/rccm.200805-686OC","article-title":"Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome","volume":"178","author":"Kim","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.13-2538_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","article-title":"Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease","volume":"185","author":"Hayashi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.13-2538_bib17","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1164\/ajrccm.158.4.9712098","article-title":"Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis","volume":"158","author":"Wallace","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.13-2538_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1086\/341207","article-title":"Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis","volume":"186","author":"Wallace","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1378\/chest.13-2538_bib19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm.156.2.atsstatement","article-title":"American Thoracic Society, Diagnosis and treatment of disease caused by nontuberculous mycobacteria","volume":"156","author":"Wallace","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.13-2538_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [published correction appears in Am J Respir Crit Care Med. 2007;175(7):744-745]","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.13-2538_bib21","series-title":"Susceptibility Testing of Mycobacteria, Norcardiae, and Other Aerobic Actinomycetes; Approved Standard","year":"2003"},{"key":"10.1378\/chest.13-2538_bib22","series-title":"Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard-Second Edition","year":"2011"},{"issue":"2","key":"10.1378\/chest.13-2538_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1378\/chest.126.2.566","article-title":"Mycobacterium avium complex pulmonary disease in patients without HIV infection","volume":"126","author":"Field","year":"2004","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.13-2538_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0732-8893(93)90112-K","article-title":"Drug intolerance to high-dose clarithromycin among elderly patients","volume":"16","author":"Wallace","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1378\/chest.13-2538_bib25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/clinids\/20.4.1073","article-title":"Clarithromycin-induced hepatotoxicity","volume":"20","author":"Brown","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1378\/chest.13-2538_bib26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/infdis\/171.3.747","article-title":"Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection","volume":"171","author":"Wallace","year":"1995","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1378\/chest.13-2538_bib27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/clinids\/21.3.594","article-title":"Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease","volume":"21","author":"Griffith","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1378\/chest.13-2538_bib28","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/clinids\/23.6.1321","article-title":"Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus\u2014negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease","volume":"23","author":"Griffith","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1378\/chest.13-2538_bib29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/clinids\/24.5.958","article-title":"Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease","volume":"24","author":"Brown","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1378\/chest.13-2538_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/clinids\/24.1.92","article-title":"Clarithromycin-associated digoxin toxicity in the elderly","volume":"24","author":"Brown","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1378\/chest.13-2538_bib31","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1378\/chest.13-2538_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/JCM.02443-12","article-title":"Mycobacterial interspersed repetitive-unit-variable-number tandem-repeat (MIRU-VNTR) genotyping of Mycobacterium intracellulare for strain comparison with establishment of a PCR-based database","volume":"51","author":"Iakhiaeva","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1378\/chest.13-2538_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/519383","article-title":"The recovery of Mycobacterium avium-intracellulare complex (MAC) from the residential bathrooms of patients with pulmonary MAC","volume":"45","author":"Nishiuchi","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1378\/chest.13-2538_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3201\/eid1703.101510","article-title":"Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease","volume":"17","author":"Falkinham","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1378\/chest.13-2538_bib35","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.200603-450OC","article-title":"Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease","volume":"174","author":"Griffith","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.13-2538_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/CMR.05030-11","article-title":"Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria","volume":"25","author":"Brown-Elliott","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1378\/chest.13-2538_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.drup.2012.04.001","article-title":"Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria","volume":"15","author":"van Ingen","year":"2012","journal-title":"Drug Resist Updat"},{"issue":"7","key":"10.1378\/chest.13-2538_bib38","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","author":"Prevots","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1378\/chest.13-2538_bib39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1164\/rccm.201003-0503OC","article-title":"Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease","volume":"182","author":"Winthrop","year":"2010","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215488166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215488166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:21:46Z","timestamp":1757920906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215488166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0012369215488166"],"URL":"https:\/\/doi.org\/10.1378\/chest.13-2538","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrolide\/Azalide Therapy for Nodular\/Bronchiectatic Mycobacterium avium Complex Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.13-2538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1378\/chest.14-0046","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}